TRAF6 and prostate carcinoma: Further, a study by Hamidi et al. [246] demonstrated that in prostate cancer cells, TRAF6 can polyubiquitylate p85α, a regulatory subunit of PI3K, and make a complex between p85α and TGF-βRI to activate PI3K and AKT.